Rejuvenate Biomed doses first subject in COPD-related muscle weakness trial
In a Phase I trial, RJx-01 showed improvements in muscle strength and fatigue resistance in healthy older male subjects.
Clinical Trials
Sarepta reports outcomes from trial of Duchenne muscular dystrophy therapy
IQVIA and SCRI partner to enhance oncology trials
Sellas doses first paediatric subject with AML in Phase II trial of SLS009
AviadoBio begins Phase I/II trial of FTD-GRN gene therapy in the UK
MSD’s Phase III trial of Keytruda meets endpoint for treating ovarian cancer
First subject dosed in Revolution Medicines’ Phase III NSCLC treatment trial
Pasithea to commence Phase I/Ib trial of neurofibromatosis type 1 therapy
